Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04610684
Title Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.